Review Article
Volume 2023, Article ID 23763982, 5 pages
Bisphosphonate-Related Osteonecrosis of the Jaws: A Review
Pradeep Christopher
Professor, Department of Oral and Maxillofacial Surgery, Thai Moogambigai Dental College and Hospital, Chennai.
Address for Correspondence:
Pradeep Christopher,
MDS Professor and Head of the Department, Department of Oral and Maxillofacial Surgery, Thai Moogambigai Dental College and Hospital, Chennai, Tamilnadu - 600037.
Email: pradeepchris68@gmail.com Mobile No: 7871221100
Abstract
Bisphosphonate drugs can be used to prevent and treat osteoporosis and to reduce symptoms and complications of metastatic bone disease. However, they are associated with a rare but serious adverse event: osteonecrosis of the maxillary and mandibular bones. This condition is called bisphosphonate-related osteonecrosis of the jaw or BRONJ. Various articles have been reviewed on different treatment modalities used along with bisphosphonates, their side effects, and management. In this review article, data from different studies with different treatment modalities were carefully analyzed and drafted.
Keywords:
Bisphosphonates, osteonecrosis, medical management, surgical management
Financial support and sponsorship -
Nil
Conflicts of interest -
There are no conflicts of interest.
How to Cite this Article:
Pradeep Christopher. (2023). Bisphosphonate-Related Osteonecrosis of the Jaws: A Review: Review Article. International Journal of Cranio Maxillofacial Surgery and Rehabilitation, 5. https://doi.org/10.56501/intjcraniomaxillofacsurgrehab.2023.835